Back to Search Start Over

Clinical Laboratory Perspective on Streptococcus halichoeri, an Unusual Nonhemolytic, Lancefield Group B Streptococcus Causing Human Infections

Authors :
Jill E. Clarridge
Mark Feldman
Thomas R. Fritsche
Susan E Sharp
Rahul Gill
Mark A. Fisher
E. Susan Slechta
Salika M. Shakir
Jonathan Salberg
Source :
Emerging Infectious Diseases, Vol 27, Iss 5, Pp 1309-1316 (2021), Emerging Infectious Diseases
Publication Year :
2021
Publisher :
Centers for Disease Control and Prevention (CDC), 2021.

Abstract

Streptococcus halichoeri is a relatively newly identified species of pyogenic streptococci that causes zoonotic infection in humans. S. halichoeri was first described in 2004 as indigenous to seals, and only 8 reports of human S. halichoeri infection have been published. S. halichoeri grows as small, white, nonhemolytic colonies and may be strongly catalase-positive on routine blood agar media, which can lead to isolates being misidentified as coagulase-negative staphylococci. S. halichoeri tests positive for Lancefield group B antigen, like S. agalactiae, but can be identified with matrix-assisted laser desorption/ionization time of flight mass spectrometry or partial 16S rRNA sequencing. We describe 3 cases of S. halichoeri bone and joint infections in patients in the United States with underlying health conditions. In addition, we examine the microbiologic characteristics of S. halichoeri and discuss the importance of fully identifying this organism that might otherwise be disregarded as a skin commensal.

Details

ISSN :
10806059 and 10806040
Volume :
27
Database :
OpenAIRE
Journal :
Emerging Infectious Diseases
Accession number :
edsair.doi.dedup.....532f048a63fd40728cf4c55d48903171
Full Text :
https://doi.org/10.3201/eid2705/203428